Mohawk Industries’ stock rallies as flooring-products maker draws upgrade on boosted profit view

Date:

July 26, 2024

Mohawk Industries Inc.’s stock jumped 16% on Friday after the maker of flooring products said it would beat analyst estimates for its third quarter and revealed plans to cut more costs, and after drawing an upgrade to buy from hold from BofA Securities.

Source link

Recall of Boar's Head deli meats announced during investigation of listeria outbreak

'Awfully weird': Trump 'absolutely' regretting picking JD Vance

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Mohawk Industries’ stock rallies as flooring-products maker draws upgrade on boosted profit view

Recent posts

Nvidia CEO’s swagger isn’t enough to support the stock, as tiny cracks emerge

Tommy Bahama maker says shoppers are still ‘more cautious than originally anticipated,’ but cites this improvement

Macy’s stock tumbles after takeover talks with Arkhouse and Brigade were ended

Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug

Bond investors position for new debt from Goldman Sachs and Morgan Stanley

These maps show the oil and gas infrastructure in Francine’s path

Interactive Brokers accepts $48 million loss tied to NYSE glitch

Stocks usually see double-digit gains under U.S. presidents — with two exceptions since 1933

Domino’s Pizza tops profit expectations but misses sales view

Chipotle’s stock rallies as renewed focus on quicker service helps second-quarter results

ADP jobs report shows 143,000 gain. Cooling U.S. labor market leads to slower wage increases.

Freight demand is weak, but cost cuts help C.H. Robinson boost profits. Shares are rallying.

Colgate-Palmolive beats profit views, even as prices fall in North America again

Oil prices fall after weak China data sparks demand concerns

Eli Lilly’s Zepbound pricing shuffle leaves some patients fearing higher costs

Related articles

Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS

Powell says Fed doesn’t need to hurry to cut interest rates

Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug

Off-price retailers could thrive, BofA says, citing this bullish data point

Republicans clinch control of House, setting stage for quicker action on extending tax cuts

This biotech’s stock could double if its treatment for major depressive disorder succeeds, says Mizuho

Cava is riding a strong wave, but the stock’s quadrupling in 2024 has analysts wary

Wells Fargo touches all-time high as analyst hikes price target to new level

Company

Follow us